← Leaderboards
Bryan Quilty Spring
Northeastern University
$5,650,243
Attributed
$6,428,371
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,428,371 · 7
By mechanism
R01$3,102,638 · 1
U01$1,556,256 · 1
P01$643,940 · 2
K22$558,923 · 1
R21$413,740 · 1
F32$152,874 · 1
Top collaborators
- Heiko Enderling3 shared
Most similar at Northeastern University
Same institution · by research overlap
- Vladimir P Torchilin$17,600,879
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorCancer CellTumorMouse ModelFluorescenceImageIn VivoIn VitroChemotherapyProtocols DocumentationMalignant NeoplasmsRecurrenceCancer TherapyRegimenNeoplastic CellOperative Surgical ProceduresDesignImage GuidedResponseCellsBiological MarkersComplexMolecular TargetCalibration
Grant awards (19)
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer$536,528
U01 · FY2025 · CA · contact PI
Multiplexed and dynamically targeted photoimmunotherapy of heterogeneous, chemoresistant micrometastases guided by online in vivo optical imaging of cell-surface biomarkers$577,549
R01 · FY2024 · CA · contact PI
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer$490,448
U01 · FY2024 · CA · contact PI
Disease-homing light delivery by engineering bioluminescent immune cells for whole body precision photomedicine$177,296
R21 · FY2024 · CA · contact PI
Core B: Biological Models, Multiplexed Optical Biopsy, Molecular Pathology, and Biostatistics Core$169,322
P01 · FY2024 · CA · contact PI
Multiplexed and dynamically targeted photoimmunotherapy of heterogeneous, chemoresistant micrometastases guided by online in vivo optical imaging of cell-surface biomarkers$604,413
R01 · FY2023 · CA · contact PI
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer$529,280
U01 · FY2023 · CA · contact PI
Disease-homing light delivery by engineering bioluminescent immune cells for whole body precision photomedicine$236,444
R21 · FY2023 · CA · contact PI
Core B: Biological Models, Multiplexed Optical Biopsy, Molecular Pathology, and Biostatistics Core$234,559
P01 · FY2023 · CA · contact PI
Multiplexed and dynamically targeted photoimmunotherapy of heterogeneous, chemoresistant micrometastases guided by online in vivo optical imaging of cell-surface biomarkers$620,611
R01 · FY2022 · CA · contact PI
Core B: Biological Models, Multiplexed Optical Biopsy, Molecular Pathology, and Biostatistics Core$240,059
P01 · FY2022 · CA · contact PI
Multiplexed and dynamically targeted photoimmunotherapy of heterogeneous, chemoresistant micrometastases guided by online in vivo optical imaging of cell-surface biomarkers$644,239
R01 · FY2021 · CA · contact PI
Multiplexed and dynamically targeted photoimmunotherapy of heterogeneous, chemoresistant micrometastases guided by online in vivo optical imaging of cell-surface biomarkers$655,826
R01 · FY2020 · CA · contact PI
Online monitoring and image-guided treatment of chemoresistant micrometastases$186,251
K22 · FY2017 · CA · contact PI
Online monitoring and image-guided treatment of chemoresistant micrometastases$186,396
K22 · FY2016 · CA · contact PI
Online monitoring and image-guided treatment of chemoresistant micrometastases$186,276
K22 · FY2015 · CA · contact PI
Hyperspectral Microendscopy to Monitor VEGF During Pancreatic Cancer Therapy$53,942
F32 · FY2012 · CA · contact PI
Hyperspectral Microendscopy to Monitor VEGF During Pancreatic Cancer Therapy$51,326
F32 · FY2011 · CA · contact PI
Hyperspectral Microendscopy to Monitor VEGF During Pancreatic Cancer Therapy$47,606
F32 · FY2010 · CA · contact PI